相关实验视频

Updated: Jun 6, 2025

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

对急性髓性白血病的蛋白质基因组分析,以确定治疗点

Heather C Murray^1,2, Jonathan Sillar^1,2,3, Maddison Chambers^1,2

¹School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, Australia.

Expert review of proteomics

|November 22, 2024

概括

蛋白质基因组分析通过整合基因组和蛋白质基因组数据来增强对急性髓性白血病 (AML) 的理解. 这种方法确定了AML的新治疗点和生物标志物,改进了治疗策略.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
蛋白质组学是指蛋白质组学.

背景情况:

急性髓性白血病 (AML) 是一种具有高复发率的侵袭性血液癌症.
基因组分析已经确定了一些治疗点,但只有50%的AML患者具有可用药物的突变.
在AML的异质性使得识别强大的治疗目标具有挑战性.

研究的目的:

审查最近在AML中结合基因组和蛋白质组分析 (蛋白质组分析) 的研究.
突出蛋白质基因组分析的潜力,以发现治疗点和生物标志物.
讨论其他omics方法的整合,如蛋白质组学.

主要方法:

用Pubmed进行的研究的文献综述.
分析整合基因组,蛋白质组和蛋白质组数据的研究.
评估蛋白质基因组分析对了解反洗钱的作用.

主要成果:

蛋白质基因组分析为AML细胞路径和白血病发生提供了深入的见解.
这种方法有助于发现AML的新型治疗标和响应生物标志物.
新兴生物标志物通过现有工作流程显示出临床翻译的潜力.

结论:

蛋白质基因组分析是推动AML研究和治疗的强大工具.
蛋白质组测试的标准化对于常规的临床整合是必要的.
蛋白质基因组特征的适应性有助于当前的临床翻译工作.

关键词:

急性髓性白血病是什么?急性髓性白血病是什么?生物标志物生物标志物光蛋白质组学光蛋白质组学光蛋白质组学精密疗法是指精确的治疗方法.蛋白质基因组学蛋白质组学蛋白质组学

更多相关视频

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...